

Choi MH, Hung IFN. Beyond ritonavir-boosted nirmatrelvir: the case for ensitrelvir in COVID-19 treatment. Lancet Infect Dis 2025; published online Oct 10. https://doi.org/10.1016/S1473-3099(25)00549-3—In this Comment, the first author's name has been corrected to Ming Hong Choi. This correction has been made to the online version as of Oct 22, 2025, and will be made to the printed version.
Infectious Diseases
|15th Jan, 2026
|The Lancet
Infectious Diseases
|15th Jan, 2026
|The Lancet
Infectious Diseases
|15th Jan, 2026
|The Lancet
Infectious Diseases
|15th Jan, 2026
|The Lancet
Infectious Diseases
|15th Jan, 2026
|The Lancet
Infectious Diseases
|15th Jan, 2026
|The Lancet
Infectious Diseases
|15th Jan, 2026
|The Lancet